BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Goh ZY, Ren EC, Ko HL. Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B. World J Gastroenterol 2021; 27(14): 1369-1391 [PMID: 33911462 DOI: 10.3748/wjg.v27.i14.1369]
URL: https://www.wjgnet.com/1007-9327/full/v27/i14/1369.htm
Number Citing Articles
1
Yi He, Yingzhi Zhou, Huimin Wang, Xiaorong Peng, Yunan Chang, Peng Hu, Hong Ren, Hongmei Xu. The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis BBMC Pediatrics 2022; 22(1) doi: 10.1186/s12887-022-03482-0
2
Guo-Qing Yin, Ke-Ping Chen, Xiao-Chun Gu. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatmentWorld Journal of Gastroenterology 2022; 28(40): 5784-5800 doi: 10.3748/wjg.v28.i40.5784
3
Zhijing Yang, Baozhen Sun, Jingcheng Xiang, Han Wu, Shaoning Kan, Ming Hao, Lu Chang, Huimin Liu, Dongxu Wang, Weiwei Liu. Role of epigenetic modification in interferon treatment of hepatitis B virus infectionFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1018053